Gainers

  • Renovaro Biosciences RENB shares increased by 292.9% to $3.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $212.7 million.
  • Decibel Therapeutics DBTX shares moved upwards by 75.26% to $4.89. The company's market cap stands at $122.3 million.
  • Tango Therapeutics TNGX shares rose 33.68% to $5.12. The market value of their outstanding shares is at $452.9 million. As per the news, the Q2 earnings report came out 2 days ago.
  • 180 Life Sciences ATNF shares increased by 32.24% to $1.02. The market value of their outstanding shares is at $5.4 million.
  • Mirati Therapeutics MRTX stock increased by 21.11% to $33.67. The company's market cap stands at $1.9 billion. The company's, Q2 earnings came out yesterday.
  • Akanda AKAN stock rose 19.35% to $0.72. The company's market cap stands at $2.8 million.

Losers

  • Palisade Bio PALI shares fell 66.1% to $0.66 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.4 million.
  • Doximity DOCS shares fell 23.0% to $25.25. The market value of their outstanding shares is at $4.9 billion. The company's, Q1 earnings came out yesterday.
  • Vivos Therapeutics VVOS stock declined by 18.11% to $0.33. The market value of their outstanding shares is at $9.8 million.
  • Monopar Therapeutics MNPR shares declined by 14.83% to $0.74. The company's market cap stands at $9.7 million.
  • BioLife Solns BLFS shares fell 13.0% to $16.0. The market value of their outstanding shares is at $695.7 million. As per the press release, Q2 earnings came out yesterday.
  • Comera Life Sciences CMRA stock fell 11.36% to $0.58. The market value of their outstanding shares is at $12.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!